skitahoe
13 minutes ago
Marty, my $27 price was based on DCVax-L being approved by the four regulators that conducted the trial. That would have DCVax-L available in all of Europe, Canada, and the US. What price would you predict if this were true and sales were coming in from all these countries for GBM patients alone.